Table 4 Cost-benefit analyses
From: The economics of malaria control and elimination: a systematic review
Country or setting | Study period | Focus (control or elimination) | Benefit-cost ratio | Source | Quality assessment score (out of 10) |
|---|---|---|---|---|---|
Global | 2010–2030 | Elimination | 6.11 | [77] | 7 |
Greece | 1946–1949 | Elimination | 17.09a | [76] | 1 |
India | 1953–1954, 1976–1977 | Control | 9.27 | [39] | 6 |
2000–2001 | Control | 4.14a | [75] | 3 | |
Iraq | 1958–1967 | Elimination | 6.3a | [73] | 3 |
Paraguay | 1965 | Elimination | 2.6–3.3 | [74] | 3 |
Philippines | Unspecified | Control | 2.4 | [16] | NA |
Sri Lanka | 1947–1955 | Control | 146.3 | [16] | NA |
Sub-Saharan Africa | Varies by study | Control | 1.9–17.1 | [10] | NA |
Sudan | 1977–1984 | Control | 4.6 | [16] | NA |
Thailand | Unspecified | Control | 6.5 | [16] | NA |
West Pakistan | 1960 | Control | 4.9 | [16] | NA |
Zambia | 1929–1949 | Control | 0.57a | [34] | 9 |
2006–2015 | Control | 40 | [29] | 6 |